Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Nausea is one of the most commonly reported side effects of weight loss injections, particularly those containing GLP-1 receptor agonists such as semaglutide (Wegovy) and liraglutide (Saxenda)
Semaglutide has a plasma half-life of approximately 165 hours (roughly 7 days), enabling once-weekly dosing
Clinical Data Clinical Trial Results 28.7% Average Weight Loss 68 weeks 58.6% Achieved 25%+ Loss of participants 445 Trial Participants Phase 3 Data from the Phase 3 TRIUMPH-4 trial of retatrutide, reported by Eli Lilly (topline, 2025)
By supporting efficient nutrient delivery, it contributes to overall metabolic wellness and cellular function, including support for the bodys natural fat-burning processes
Lancet Infect Dis 2020;20:398400 3
Billing is monthly and injection-only, with nothing charged until a licensed provider approves the prescription
US$ 20.59
US$ 28.42
US$ 24.58
US$ 22.50
US$ 29.36
US$ 24.67
US$ 23.33
.webp)
US$ 28.66
